Efficacy and Safety of Secukinumab in Patients with Plaque Psoriasis and Latent Tuberculosis
Authors:
Open Access
- 23 September 2019
- journal article
- research article
- Published by S. Karger AG in Case Reports in Dermatology
- Vol. 11 (Suppl. 1) , 23-28
Abstract
Upon the association of biologic treatments with reactivation of latent tuberculosis infection (LTBI), screening for Mycobacterium tuberculosisinfection and anti-tuberculosis chemoprophylaxis in positive patients are required prior to biologic drug administration. Nevertheless, the risk of infection relapses associated with biologic drugs seems to be different. No cases of reactivation of LTBI have been observed in secukinumab-treated subjects, in contrast with clinical reports on the risk associated with anti-tumor necrosis factor α-based therapy. Twelve patients with moderate to severe plaque psoriasis eligible for systemic treatment and found to have LTBI received secukinumab without previous chemoprophylaxis initiation because of clinical contraindication for 10 cases and refusal by 2 patients. None of them had tuberculosis reactivation.Keywords
This publication has 28 references indexed in Scilit:
- IL-17+ γδ T cells as kick-starters of inflammationNature Immunology, 2017
- Italian guidelines on the systemic treatments of moderate‐to‐severe plaque psoriasisJournal of the European Academy of Dermatology and Venereology, 2017
- Cytokines and Chemokines inMycobacterium tuberculosisInfectionMicrobiology Spectrum, 2016
- Updates on the risk factors for latent tuberculosis reactivation and their managementsEmerging Microbes & Infections, 2016
- Unexpected Role for IL-17 in Protective Immunity against Hypervirulent Mycobacterium tuberculosis HN878 InfectionPLOS Pathogens, 2014
- Mice genetically inactivated in interleukin‐17A receptor are defective in long‐term control of Mycobacterium tuberculosis infectionImmunology, 2013
- Immunity to infection in IL‐17‐deficient mice and humansEuropean Journal of Immunology, 2012
- How tumour necrosis factor blockers interfere with tuberculosis immunityClinical and Experimental Immunology, 2010
- Essential Role of IL-17A in the Formation of a Mycobacterial Infection-Induced Granuloma in the LungThe Journal of Immunology, 2010
- Interleukin 17-Producing γδ T Cells Increased in Patients with Active Pulmonary TuberculosisCellular & Molecular Immunology, 2008